Diagnosis and surgical treatment of cavernous sinus hemangiomas: an experience of 20 cases
- PMID: 12865008
- DOI: 10.1016/s0090-3019(03)00190-3
Diagnosis and surgical treatment of cavernous sinus hemangiomas: an experience of 20 cases
Abstract
Objective: To elucidate the advances of diagnosis and surgical treatment of the cavernous sinus hemangiomas (CSHs).
Methods: The data from 20 patients with the CSHs surgically treated by authors from 1996 through 2000 was analyzed retrospectively, and a review of relevant literature was conducted.
Results: These 20 cases accounted for 16.3% of all intracranial cavernous hemangiomas surgically treated in the same period at Huashan Hospital. The patients were aged from 32 approximately 69 years with an average age of 47 years. There were 17 females and 3 males. The common clinical manifestations were visual loss, diplopia, headache, facial numbness and extraocular muscle palsy. Computed tomography (CT) and magnetic resonance imaging (MRI) were major preoperative diagnostic modalities, but demonstrated nonspecific features. The preoperative misdiagnostic rate was 38.9%. Of the 20 patients undergoing craniotomy via modified pterional approach with or without orbitozygomatic osteotomy, tumors were removed through epidural approach (EDA) in 13 cases, intradural approach (IDA) in 7 cases. Hypotension was induced during the operation in 2 cases. Total tumor removal was achieved in 12 cases (92.3%) in the EDA group and nil in the IDA group. Incomplete tumor removal was 1 case (7.7%) in the EDA group and 7 cases (100%) in the IDA group. One patient in the IDA group died of intracranial hemorrhage postoperatively. Compared with preoperative manifestations, cranial neuropathies at discharge were worsened in 76.9% of patients in the EDA group and 83.3% of patients in the IDA group, improved in 15.4% of patients in the EDA group and 16.7% of patients in the IDA group, unchanged in 7.7% of patients in the EDA group. Follow-up study (range, 1 approximately 6 years; mean, 3 years) was available in 17 patients (89%). All patients in the EDA group improved without tumor recurrence. Nonimprovement (2 cases) and continued worsening (3 cases) occurred in the IDA group. In patients with tumor incompletely removed, the tumor enlarged in 2 cases, and unchanged or decreased in size in 3 cases, in which 2 cases underwent postoperative radiosurgery or radiotherapy. According to pathologic and MRI characteristics, the CSHs can be divided into two types, sponge-like type and mulberry-like type.
Conclusion: Cavernous hemangioma should be included in differential diagnosis for middle aged females with cavernous sinus tumors. Two types of the CSHs, sponge-like type and mulberry-like type, can be identified. The best microsurgical approach for the removal of the CSHs is epidural approach via the skull-base craniotomy. Radiosurgery should be considered for patients with incomplete tumor removal.
Similar articles
-
Cavernous sinus cavernous hemangioma: imaging features and therapeutic effect of Gamma Knife radiosurgery.Clin Neurol Neurosurg. 2014 Dec;127:59-64. doi: 10.1016/j.clineuro.2014.09.025. Epub 2014 Oct 5. Clin Neurol Neurosurg. 2014. PMID: 25459244
-
Clinical Features, Intradural Transcavernous Surgical Management, and Outcomes of Giant Cavernous Sinus Hemangiomas: A Single-Institution Experience.World Neurosurg. 2019 May;125:e754-e763. doi: 10.1016/j.wneu.2019.01.165. Epub 2019 Feb 5. World Neurosurg. 2019. PMID: 30735865
-
[Microsurgical treatment of nonmeningeal tumors of the cavernous sinus].Zhonghua Yi Xue Za Zhi. 2005 Jun 1;85(20):1373-8. Zhonghua Yi Xue Za Zhi. 2005. PMID: 16029646 Chinese.
-
Phase II study to assess the efficacy of hypofractionated stereotactic radiotherapy in patients with large cavernous sinus hemangiomas.Int J Radiat Oncol Biol Phys. 2012 Jun 1;83(2):e223-30. doi: 10.1016/j.ijrobp.2011.12.051. Epub 2012 Feb 21. Int J Radiat Oncol Biol Phys. 2012. PMID: 22361080 Review.
-
Is endoscopic resection a useful technique for a cavernous sinus sellar cavernoma? A case report and literature review.Br J Neurosurg. 2024 Jun;38(3):781-788. doi: 10.1080/02688697.2021.1958154. Epub 2021 Aug 18. Br J Neurosurg. 2024. PMID: 34406095 Review.
Cited by
-
Stereotactic radiosurgery for cavernous sinus hemangiomas.J Neurooncol. 2014 May;118(1):163-8. doi: 10.1007/s11060-014-1414-5. Epub 2014 Mar 2. J Neurooncol. 2014. PMID: 24584749
-
Temporal Volume Change of Cavernous Sinus Cavernous Hemangiomas after Gamma Knife Surgery.Yonsei Med J. 2020 Nov;61(11):976-980. doi: 10.3349/ymj.2020.61.11.976. Yonsei Med J. 2020. PMID: 33107242 Free PMC article.
-
Cavernous sinus haemangioma with intrasellar extension mimicking non-functioning pituitary adenoma - A case report and review of literature.Rep Pract Oncol Radiother. 2019 Sep-Oct;24(5):458-461. doi: 10.1016/j.rpor.2019.07.001. Epub 2019 Aug 1. Rep Pract Oncol Radiother. 2019. PMID: 31406488 Free PMC article.
-
Safety and efficacy of single-fraction gamma knife radiosurgery for benign confined cavernous sinus tumors: our experience and literature review.Neurosurg Rev. 2020 Feb;43(1):27-40. doi: 10.1007/s10143-018-0975-8. Epub 2018 Apr 9. Neurosurg Rev. 2020. PMID: 29633079 Review.
-
Intracranial Virotherapy for a Canine Hemangioma.Int J Mol Sci. 2022 Oct 2;23(19):11677. doi: 10.3390/ijms231911677. Int J Mol Sci. 2022. PMID: 36232978 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical